Tryptophan Metabolism Through the Kynurenine Pathway in Glial Cells
Authors:
- Deivison Silva ArgoloDADeivison Silva Argolo
- Lucas Matheus Gonçalves de OliveiraLOLucas Matheus Gonçalves de Oliveira
- Gilles J. GuilleminGilles J. Guillemin
- George E. BarretoGeorge E. Barreto
- Arthur Morgan ButtArthur Morgan Butt
- Silvia Lima CostaSCSilvia Lima Costa
- Maria de Fátima Dias CostaMCMaria de Fátima Dias Costa
Open Access
Abstract
The central nervous system (CNS) relies on complex and dynamic interactions between neurons and glial cells. Among glial cells, astrocytes regulate the chemical environment surrounding neurons and supply essential nutrients for brain metabolism whereas microglia, the resident macrophages of the CNS, play critical roles in homeostasis, defense, and responses to injury. Both microglia and astrocytes contribute to the regulation of excitotoxicity and inflammation mediated by the metabolism of tryptophan (Trp) via the kynurenine pathway. Trp metabolism generates several bioactive metabolites, including quinolinic acid (QUIN) and kynurenic acid (KYNA), which have opposing effects. QUIN, produced by activated microglia, acts as an agonist for NMDA receptors; excessive stimulation of these receptors can lead to excitotoxicity and neuronal death. Conversely, KYNA, primarily produced by astrocytes via kynurenine 2,3-aminotransferases (KAT), acts as an NMDA receptor antagonist, conferring neuroprotection by mitigating excitotoxicity. Dysregulation of the Trp metabolism is implicated in many neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis and amyotrophic lateral sclerosis, as well as in various neuropsychiatric disorders. This review examines the cellular and molecular mechanisms underlying Trp metabolism in glial cells, highlighting the unique contributions of each glial phenotype, the implications for CNS pathologies, and the potential biomarkers and therapeutic targets for restoring homeostasis and preventing disease progression.Keywords
Funding Information
- Bahia State Research Support Foundation (FAPESB) (BOL0284/2020, 312388/2021-7, 407833/2023-4)
- National Council for Scientific and Technological Development (CNPq) (BOL0284/2020, 312388/2021-7, 407833/2023-4)
- National Institute for Translational Neuroscience—INNT Brazil (BOL0284/2020, 312388/2021-7, 407833/2023-4)
This publication has 143 references indexed in Scilit:
- Serum indoleamine 2, 3-dioxygenase and tryptophan-2, 3-dioxygenase: potential biomarkers for the diagnosis of major depressive disorderPsychopharmacology, 2024
- Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in MiceNeurochemical Research, 2020
- The glia/neuron ratio: How it varies uniformly across brain structures and species and what that means for brain physiology and evolutionGlia, 2014
- Alzheimer’s Disease2012
- Targeted Activation of Astrocytes: A Potential Neuroprotective StrategyMolecular Neurobiology, 2008
- A not entirely benign procedure: progression of Parkinson’s diseaseActa Neuropathologica, 2008
- Demonstration of Kynurenine Aminotransferases I and II and Characterization of Kynurenic Acid Synthesis in Oligodendrocyte Cell Line (OLN-93)Neurochemical Research, 2005
- Expression of indoleamine 2,3‐dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neuronsGlia, 2004
- Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytesGlia, 2003
- Excitotoxicity, energy metabolism and neurodegenerationJournal of Inherited Metabolic Disease, 1993